Myriapod® NGS Onco panel cat.no. NG052 Thermo Fisher® (48 test, CE IVD)
Features
Principle of the method: Myriapod® NGS 56G Onco panel CE IVD kit allows the detection of the main variants of 56 genes whose alteration has been shown to be clinically relevant in different tumors.
Starting material: genomic DNA extracted from fresh or formalin-fixed paraffin embedded (FFPE) tissue.
Intended use: CE IVD workflow from DNA to data analysis of 56 genes whose alterations have been shown to be of clinical relevance in oncology.
Genes included in the panel:
Products in Myriapod NGS Line
| SKU | Name | description |
|---|---|---|
| NG030 | Myriapod® NGS BRCA1-2 panel cat.no. NG030 Illumina® (48 test, CE IVD) | Myriapod® NGS BRCA1-2 panel cat.no. NG030 Illumina® (48 test, CE IVD) |
| NG050 | Myriapod® NGS BRCA1-2 panel cat.no. NG050 Thermo Fisher® (48 test, CE IVD) | Myriapod® NGS BRCA1-2 panel cat.no. NG050 Thermo Fisher® (48 test, CE IVD) |
| NG900-SW | Myriapod® NGS Data Analysis Software | Myriapod® NGS Data Analysis Software |
| NG032 | Myriapod® NGS Onco panel cat.no. NG032 Illumina® (48 test, CE IVD) | Myriapod® NGS Onco panel cat.no. NG032 Illumina® (48 test, CE IVD) |
| NG052 | Myriapod® NGS Onco panel cat.no. NG052 Thermo Fisher® (48 test, CE IVD) | Myriapod® NGS Onco panel cat.no. NG052 Thermo Fisher® (48 test, CE IVD) |
| NG900-HD | Myriapod® NGS Workstation | Myriapod® NGS Workstation |
| NG031 | Myriapod® NGS-IL CFTR panel cat.no. NG031 Illumina® (48 test, CE IVD) | Myriapod® NGS-IL CFTR panel cat.no. NG031 Illumina® (48 test, CE IVD) |
Reviews
There are no reviews yet.